NAR Executive Committee 2017-2018

President

Dr Victoria Cook received her Bachelor's Degree from Brown University. She obtained her medical degree and Internal Medicine training from the University of British Columbia, and completed a fellowship in Respirology at the University of Manitoba. Dr. Cook is a Fellow of the Royal College of Physicians of Canada (Internal Medicine and Respirology). She has been based at the BC Centre for Disease Control, Division of TB Control since 2002 and is now the Medical Lead, Provincial TB Services. She is particularly interested in the implementation and evaluation of novel strategies to control tuberculosis (TB) in high-risk populations. Dr. Cook is also a member of the Respiratory Division at Vancouver General Hospital and is an Assistant Professor in the Faculty of Medicine at UBC. She is the co-chair of the British Columbia TB Strategic Committee, working to implement the Provincial Strategic Plan for TB Prevention, Treatment and Control.

Vice-President/Programme Chair

Dr James Johnston is a Clinical Assistant Professor in the Faculty of Medicine at University of British Columbia and BC Centre for Disease Control. He completed Internal medicine training at McGill University and a Respiratory Medicine Fellowship at UBC. He received postdoctoral training in Tuberculosis research at British Columbia Centre for Disease Control, and has a Master’s in Public Health from Harvard School of Public Health. His clinical interests include treatment of tuberculosis and nontuberculous mycobacterial disease. His tuberculosis research focus includes foreign-born risk factors for tuberculosis disease and the role of whole genome sequencing in understanding tuberculosis transmission dynamics. He received the Michael Smith Scholarship in 2014. Dr. Johnston has been a member of the Union’s NAR abstract committee for the past two years, and has been an abstract chair and session moderator for the Union’s international meeting.

Secretary/Treasurer

Dr Lisa V. Adams is the Associate Dean for Global Health and an Associate Professor of Medicine in the Section of Infectious Disease and International Health at Dartmouth’s Geisel School of Medicine. She oversees Dartmouth College’s Global Health Initiative at the John Sloan Dickey Center for International Understanding and is the Director of Geisel’s Center for Health Equity. In all her roles, she develops and oversees cross-cutting global health programs involving faculty and students. She has worked in domestic and international TB control for over 20 years with expertise in program management, disease surveillance, monitoring and evaluation, and clinical care. She is the former Director of Surveillance for the New York City Department of Health’s TB Control Program.  As an international TB consultant, she has worked in over a dozen countries to provide technical assistance to Ministries of Health. At Dartmouth, she teaches global health to medical and college students. She has been a co-investigator on several clinical and operations research trials on TB and HIV through the DarDar Programs, a collaboration between Dartmouth and Muhimbili University in Dar es Salaam, Tanzania. In 2012, she spent 6 months in Rwanda as Geisel’s lead to launch the major medical education initiative, the Rwandan Human Resources for Health Program. She is currently engaged with local partners in Swaziland to improve delivery of TB care services to children and persons living with HIV. She and her husband, Lars, have two teenaged children, Lucas and Lea.

President–elect

Dr Robert Horsburgh's career has been dedicated to understanding and preventing mycobacterial diseases, particularly drug-resistant tuberculosis and tuberculosis in HIV-infected persons. He is an experienced TB clinician and his research has focused on TB clinical and epidemiologic research and clinical trials. He served as Chairman of the infectious Diseases Society of America’s TB Committee, Chairman of the Steering Committee of the U.S. Tuberculosis Trials Consortium (TBTC), Chairman of the Steering Committee of the U.S. Tuberculosis Epidemiologic Studies Consortium (TBESC) and Co-Chair of the “Access and Appropriate Use Work Group” of the Gates Foundation’s Critical Path to TB Drug Regimens Initiative. He is a member of the U.S. Advisory Committee for the Elimination of Tuberculosis (ACET), which advises CDC on tuberculosis control and elimination strategy. In addition, he is Co-Chairman of the Drug-Resistance Working Group of the IUATLD, Chair of the MDR/XDR-TB Working Group of the TBTC, and Chairman of the Steering Committee of Research Excellence to Stop TB Resistance (RESIST-TB), an international organization that advocates for clinical trials of Drug-resistant TB (http://www.resisttb.org/).

Immediate Past-President

Dr Randall Reves was the Medical Director, Denver Metro Tuberculosis Control Program and a staff physician in Infectious Diseases at Denver Health Medical Center 1990 through his February 2013 retirement. He continues his clinical activities as a Volunteer Physician at Denver Metro Tuberculosis Control Program and his research career in the diagnosis, treatment and prevention of tuberculosis as an independent contractor, including participation in the Tuberculosis Epidemiologic Studies Consortium funded by the Center for Disease Control and Prevention. He is a Professor of Medicine, Infectious Diseases, Department of Medicine, and Epidemiology, School of Public Health, University of Colorado Denver. He is a member of the Coordinating Board of Stop TB USA and will serve as Chair for two years beginning in June 2016.

Past Vice-President and Programme Chair

Dr Alfred Lardizabal received his medical degree from the University of Santo Tomas in Manila, Philippines and completed training in internal medicine and pulmonary / critical care medicine at the UMDNJ-University Hospital (now Rutgers) after finishing coursework for a Masters in Public Health at Yale. He is the current Executive Director of the Global Tuberculosis Institute and Associate Professor of Medicine at Rutgers New Jersey Medical School. In addition to overseeing medical consultation services at the Global Tuberculosis Institute, Dr. Lardizabal specializes in the care of TB patients at Regional Chest Clinics in Newark, Jersey City, and Edison, New Jersey. He has served as technical consultant for various international projects such as the pharmacy public-private mix DOTS model a DOTS curriculum into allied health care education also in the Philippines. Currently, Dr. Lardizabal is the immediate Past Program Chair and Vice President for the International Union Against Tuberculosis and Lung Disease North American Region (The Union – NAR). His current research activities in collaboration with the Public Health Research Institute focuses on a novel platform for the immunological detection of Mycobacterium tuberculosis infection.

Secretariat

Menn Biagtan, MD, MPH is the Program Manager of the British Columbia Lung Association overseeing the Association’s lung health initiatives local, national and international projects. Her main One of her many responsibilities is managing the various activities of the Union-North America Region. She has been organizing the annual conference of the (which today is considered as the premier TB conference in North America) since 1998.

Ex-Officio

Scott McDonald is CEO of the British Columbia Lung Association, one of Canada’s most highly respected voluntary health agencies. Mr. McDonald graduated from the journalism programme at Ryerson University in Toronto and worked in the Canadian publishing industry and in media relations with Canada Post Corporation before joining the Lung Association in Vancouver.  In his three-decade career with the Lung Association, Scott has served on numerous committees, panels and working groups with both the Canadian and American Lung Association and has recently served as Chairman of the Communications, Fundraising and Membership Committee of the Union. Scott has an interest in many areas of public health, health policy development and in particular in air quality and tobacco control, two areas in which the Lung Association is a recognized leader.